First report on the targeted therapy of an IDH1-mutated Cholangiocarcinoma in a patient with Maffucci syndrome

被引：0
|
作者：
Peters, M. [1 ]
Lessel, D. [2 ]
Bernreuther, C. [3 ]
Iglauer, P. [3 ]
Heukamp, L. [4 ]
Velthaus, J. -L. [1 ]
Bokemeyer, C. [1 ]
Sonja, L. [1 ]
Volk, A. [2 ]
机构：
[1] Univ Klinikum Hamburg Eppendorf, Med Klin & Poliklin 2, Hamburg, Germany
[2] Univ Klinikum Hamburg Eppendorf, Inst Humangenet, Hamburg, Germany
[3] Univ Klinikum Hamburg Eppendorf UKE, Hamburg, Germany
[4] Inst Hamatopathol Hamburg, Hamburg, Germany
来源：
ONCOLOGY RESEARCH AND TREATMENT | 2020年 / 43卷 / SUPPL 4期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
426
引用
收藏
页码：123 / 123
页数：1
相关论文
共 50 条
  • [21] Energy Metabolism in IDH1 Wild-Type and IDH1-Mutated Glioblastoma Stem Cells: A Novel Target for Therapy?
    van Noorden, Cornelis J. F.
    Hira, Vashendriya V. V.
    van Dijck, Amber J.
    Novak, Metka
    Breznik, Barbara
    Molenaar, Remco J.
    CELLS, 2021, 10 (03) : 1 - 16
  • [22] A MOUSE MODEL REVEALS VULNERABILITY OF IDH1-MUTATED GLIOMA TO FERROPTOSIS
    Mela, Angeliki
    Dovas, Athanassios
    Mahajan, Aayushi
    Humala, Nelson
    Trang Nguyen
    Kanangat, Smriti
    Upadhyayula, Pavan
    Sprinzen, Lisa
    Argenziano, Michael
    Huang, Dennis
    Guo, Jia
    Casaccia, Patrizia
    Siegelin, Markus
    Stockwell, Brent
    Bruce, Jeffrey
    Canoll, Peter
    NEURO-ONCOLOGY, 2023, 25
  • [23] Outcomes of Patients with IDH1-Mutated Myeloid Neoplasms Treated with Olutasidenib
    Chien, Kelly S.
    Sasaki, Koji
    Mccue, Deborah
    Daver, Naval
    Kadia, Tapan M.
    Short, Nicholas J.
    Issa, Ghayas C.
    Montalban-Bravo, Guillermo
    Haddad, Fadi G.
    Hammond, Danielle
    Swaminathan, Mahesh
    Bazinet, Alexandre
    Ravandi, Farhad
    Garcia-Manero, Guillermo
    Pierce, Sherry
    Kantarjian, Hagop M.
    Dinardo, Courtney D.
    BLOOD, 2024, 144 : 6042 - 6043
  • [24] Durable Remissions with Ivosidenib in IDH1-Mutated Relapsed or Refractory AML
    DiNardo, C. D.
    Stein, E. M.
    de Botton, S.
    Roboz, G. J.
    Altman, J. K.
    Mims, A. S.
    Swords, R.
    Collins, R. H.
    Mannis, G. N.
    Pollyea, D. A.
    Donnellan, W.
    Fathi, A. T.
    Pigneux, A.
    Erba, H. P.
    Prince, G. T.
    Stein, A. S.
    Uy, G. L.
    Foran, J. M.
    Traer, E.
    Stuart, R. K.
    Arellano, M. L.
    Slack, J. L.
    Sekeres, M. A.
    Willekens, C.
    Choe, S.
    Wang, H.
    Zhang, V.
    Yen, K. E.
    Kapsalis, S. M.
    Yang, H.
    Dai, D.
    Fan, B.
    Goldwasser, M.
    Liu, H.
    Agresta, S.
    Wu, B.
    Attar, E. C.
    Tallman, M. S.
    Stone, R. M.
    Kantarjian, H. M.
    NEW ENGLAND JOURNAL OF MEDICINE, 2018, 378 (25): : 2386 - 2398
  • [25] Baseline characteristics and molecular testing of patients with IDH1-mutated cholangiocarcinoma: Initial results from the phase IIIb ProvIDHe study
    Rimassa, L.
    Bridgewater, J. A.
    Casadei-Gardini, A.
    Wilmink, H.
    Sim, H-W
    de Vos-Geelen, J.
    Mercade, T. Macarulla
    Malka, D.
    Gharbi, H.
    Robert, R.
    Sullivan, A.
    Vogel, A.
    ANNALS OF ONCOLOGY, 2024, 35 : S1457 - S1457
  • [26] Baseline characteristics and molecular testing of patients with IDH1-mutated cholangiocarcinoma: Initial results from the phase IIIb ProvIDHe study
    Rimassa, L.
    Bridgewater, J. A.
    Gardini, A. Casadei
    Wilmink, H.
    Sim, H-W.
    De Vos-Geelen, J.
    Mercade, T. Macarulla
    Malka, D.
    Gharbi, H.
    Robert, R.
    Sullivan, A.
    Vogel, A.
    ANNALS OF ONCOLOGY, 2024, 35 : S236 - S236
  • [27] IDH1-mutated cancer cells are sensitive to cisplatin and an IDH1-mutant inhibitor counteracts this sensitivity
    Khurshed, Mohammed
    Molenaar, Remco J.
    Wilmink, Johanna W.
    van Laarhoven, Hanneke W.
    van Noorden, Cornelis J.
    CANCER RESEARCH, 2018, 78 (13)
  • [28] Radioprotection of IDH1-Mutated Cancer Cells by the IDH1-Mutant Inhibitor AGI-5198
    Molenaar, Remco J.
    Botman, Dennis
    Smits, Myrthe A.
    Hira, Vashendriya V.
    van Lith, Sanne A.
    Stap, Jan
    Henneman, Peter
    Khurshed, Mohammed
    Lenting, Krissie
    Mul, Adri N.
    Dimitrakopoulou, Dionysia
    van Drunen, Cornelis M.
    Hoebe, Ron A.
    Radivoyevitch, Tomas
    Wilmink, Johanna W.
    Maciejewski, Jaroslaw P.
    Vandertop, W. Peter
    Leenders, William P.
    Bleeker, Fonnet E.
    van Noorden, Cornelis J.
    CANCER RESEARCH, 2015, 75 (22) : 4790 - 4802
  • [29] ACQUISITION OF WARBURG PHENOTYPE IN IDH1-MUTATED GLIOMA AS A MECHANISM OF MALIGNANT TRANSFORMATION
    Rodado, Victor Ruiz
    Seki, Tomohiro
    Dowdy, Tyrone
    Lita, Adrian
    Celiku, Orieta
    Yamamoto, Kazu
    Saito, Keita
    Saldana, Cavazos
    Li, Aiguo
    Cherukuri, Murali Krishna
    Gilbert, Mark
    Larion, Mioara
    NEURO-ONCOLOGY, 2017, 19 : 131 - 132
  • [30] Two rare cases of IDH1-mutated gliosarcomas arising in IDH1-mutated, 1p/19q non-codeleted diffuse gliomas with prominent oligodendroglial morphology
    Soukup, J.
    Bartos, M.
    Hobza, V.
    Kasparova, P.
    Kohout, A.
    Cesak, T.
    VIRCHOWS ARCHIV, 2020, 477 : S111 - S111
12345